Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 20 mg - gum, chewing - excipient ingredients: hypromellose; quinoline yellow aluminium lake; xylitol; acacia; carnauba wax; acesulfame potassium; polysorbate 80; menthol; light magnesium oxide; sodium carbonate; titanium dioxide; peppermint oil; sucralose; flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitaing smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 10 mg - gum, chewing - excipient ingredients: hypromellose; acesulfame potassium; peppermint oil; xylitol; polysorbate 80; acacia; titanium dioxide; carnauba wax; sucralose; menthol; sodium carbonate; sodium bicarbonate; light magnesium oxide; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides; flavour - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitaing smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg - lozenge - excipient ingredients: magnesium stearate; sodium carbonate; sucralose; acesulfame potassium; calcium polycarbophil; potassium bicarbonate; mannitol; sodium alginate; xanthan gum; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg - lozenge - excipient ingredients: mannitol; sucralose; acesulfame potassium; potassium bicarbonate; sodium carbonate; magnesium stearate; sodium alginate; xanthan gum; calcium polycarbophil; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 26.66 mg - lozenge - excipient ingredients: xanthan gum; calcium polycarbophil; acesulfame potassium; magnesium stearate; mannitol; sucralose; sodium alginate; potassium bicarbonate; sodium carbonate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine polacrilex, quantity: 13.33 mg - lozenge - excipient ingredients: mannitol; acesulfame potassium; potassium bicarbonate; xanthan gum; sucralose; calcium polycarbophil; magnesium stearate; sodium alginate; sodium carbonate; flavour - relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. nicotine lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. if possible, when stopping smoking, should be used in conjunction with behavioural support program.

Australia - English - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - nicotine polacrilex, quantity: 20 mg (equivalent: nicotine, qty 4 mg) - lozenge - excipient ingredients: sucralose; sodium carbonate; sodium bicarbonate; mannitol; magnesium stearate; hypromellose; xanthan gum; indigo carmine aluminium lake; acesulfame potassium; microcrystalline cellulose; crospovidone; xylitol; calcium hydrogen phosphate; flavour - for the relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. it may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. it should be used as part of a behavioural support programme.

United States - English - NLM (National Library of Medicine)

blip products, inc. - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - stop smoking aid

United States - English - NLM (National Library of Medicine)

blip products, inc. - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - stop smoking aid

United States - English - NLM (National Library of Medicine)

blip products, inc. - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - stop smoking aid